To determine the role of ZNF132 and its potential value as a biomarker in ESCC, we studied the methylation status of the ZNF132 promoter and the expression level of ZNF132 in ESCC tumors and adjacent normal tissues. This evidence concerns the gene ZNF132 and esophageal squamous cell carcinoma.